Efficacy of high-energy collimator for sentinel node lymphoscintigraphy of early breast cancer patients

Radiology and Oncology

Volumn 46, Issue 1, 2012, Pages 75-80

  Aryana, Kamran ^a   Gholizadeh, Mohaddeseh ^a   Momennezhad, Mehdi ^a   Naji, Maryam ^a   Aliakbarian, Mohsen ^b   Forghani, Mohammad Naser ^c   Sadeghi, Ramin ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

collimator; HEAP; high energy all purpose; LEHR; low energy high resolution; lymphoscintigraphy; sentinel node

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; ARTIFACT; BIOPSY; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; COLLIMATOR; EARLY BREAST CANCER; EARLY CANCER; HUMAN; HUMAN TISSUE; INJECTION SITE; LOW ENERGY HIGH RESOLUTION COLLIMATOR; LYMPHOSCINTIGRAPHY; MEDICAL SPECIALIST; SCINTILLATION CAMERA; SENTINEL NODE LYMPHOSCINTIGRAPHY;

EID: 84858263121     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0013-3     Document Type: Article

References (18)

1. Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A, et al. Assessment the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Technetium-99m phytate in breast cancer. DARU J Pharm Sci 2009; 17: 83-7.
2. Rucigaj TP, Leskovec NK, Zunter VT. Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition? Radiol Oncol 2010; 44: 244-8.
3. Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant J, Prats E, et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007; 34: 2154-9. (Pubitemid 350212147)
4. Sadeghi R, Forghani MN, Memar B, Rajabi Mashhadi MT, Dabbagh Kakhki VR, Abdollahi A, et al. How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping? Ann Nucl Med 2009; 23: 507-10.
5. Lemstra C, Broersma M, Poot L, Jager PL. Sentinel node detection in patients with breast cancer: low-energy all-purpose collimator or medium-energy collimator? Clin Nucl Med 2004; 29: 609-13. (Pubitemid 40228162)
6. Nunez M, Alonso O, Mut F, Vila R, Beretta M, Illutton BF. Detectability of sentinel nodes in lymphoscintigraphy as a function of collimator type and distance from the injection site: A phantom study. J Nucl Med Technol 2004; 32: 105-6.
7. Tsushima H, Takayama T, Yamanaga T, Kizu H, Shimonishi Y, Kosakai K, et al. Usefulness of medium-energy collimator for sentinel node lymphoscintigraphy imaging in breast cancer patients. J Nucl Med Technol 2006; 34: 153-9. (Pubitemid 46940853)
8. Tsushima H, Takayama T, Kizu H, Yamanaga T, Shimonishi Y, Kosakai K, et al. Advantages of upright position imaging with medium-energy collimator for sentinel node lymphoscintigraphy in breast cancer patients. Ann Nucl Med 2007; 21: 123-8. (Pubitemid 46495612)
9. Krynyckyi BR, Sata S, Zolty I, Kim DW, Kim SC, Knesaurek K. Sentinel node detection in patients with breast cancer: low-energy all-purpose collimator or medium-energy collimator? Clin Nucl Med 2005; 30: 369-70. (Pubitemid 40569800)
10. Fenestra C, Lansbergen SM, Busemann-Sokole E, Sloof GW. Imaging of the sentinel nodes comparing different collimators. Eur J Nucl Med 2000; 27: 1006.
11. Momennezhad M, Zakavi SR, Dabbagh Kakhki VR, Jangjoo A, Ghavamnasiri MR, Sadeghi R. Scatterogram: a method for outlining the body during lymphoscintigraphy without using external flood source. Radiol Oncol 2011; 45: 184-8.
12. Design calculator. Nuclear Fields Website: http://www.nuclearfields.com/ collimators-design-calculator.htm. Accessed on 1 June 2011.
13. Somasundaram SK, Chicken DW, Waddington WA, Bomanji J, Ell PJ, Keshtgar MR. Sentinel node imaging in breast cancer using superficial injections: technical details and observations. Eur J Surg Oncol 2009; 35:1250-6.
14. Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, Zakavi SR, Memar B, Forghani MN, et al. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Rev Esp Med Nucl 2010; 29: 73-7.
15. Tsushima H, Yamanaga T, Shimonishi Y, Ochi H. Usefulness of imaging method without using lead plate for sentinel lymph node scintigraphy. Kaku Igaku 2002; 39: 161-9.
16. Jastrzebski T, Kopacz A, Lass P. Comparison of peritumoral and subareolar injection of Tc99m sulphur colloid and blue-dye for detection of the sentinel lymph node in breast cancer. Nucl Med Rev Cent East Eur 2002; 5: 159-61. (Pubitemid 36054678)
17. Maza S, Thomas A, Winzer KJ, Huttner C, Blohmer JU, Hauschild M, et al. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients. Eur J Nucl Med Mol Imaging 2004; 31: 671-5. (Pubitemid 38647905)
18. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001; 42: 1198-215. (Pubitemid 32717839)